Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Omnicell, Inc.    OMCL

OMNICELL, INC.

(OMCL)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/20/2020 10/21/2020 10/22/2020 10/23/2020 10/26/2020 Date
80.7(c) 81.74(c) 83.63(c) 84.47(c) 84.1(c) Last
733 292 703 205 1 091 949 854 083 352 126 Volume
+1.38% +1.29% +2.31% +1.00% -0.44% Change
More quotes
Financials (USD)
Sales 2020 876 M - -
Net income 2020 30,0 M - -
Net Debt 2020 - - -
P/E ratio 2020 122x
Yield 2020 -
Sales 2021 1 001 M - -
Net income 2021 76,4 M - -
Net Debt 2021 - - -
P/E ratio 2021 48,7x
Yield 2021 -
Capitalization 3 612 M 3 612 M -
Capi. / Sales 2020 4,12x
Capi. / Sales 2021 3,61x
Nbr of Employees 2 780
Free-Float 81,3%
More Financials
Company
Omnicell, Inc. provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment is engaged in... 
More about the company
Notations Surperformance© of Omnicell, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about OMNICELL, INC.
10/22OMNICELL : Lehigh Valley Health Network Chooses Omnicell Solutions to Enhance Cl..
BU
10/20OMNICELL : Memorial Hospital at Gulfport Selects Omnicell Central Pharmacy Dispe..
BU
10/06OMNICELL : Launches EnlivenHealth™ to Aid Retail Pharmacies and Health Pla..
BU
10/01OMNICELL, INC : Regulation FD Disclosure (form 8-K)
AQ
10/01OMNICELL : Completes Acquisition of Pharmaceutical Strategy Group's Leading 340B..
BU
09/29OMNICELL : to Release Third Quarter 2020 Earnings Results on October 27, 2020
BU
09/25OMNICELL, INC : Entry into a Material Definitive Agreement, Creation of a Direct..
AQ
09/23OMNICELL, INC. : Prices $500 Million 0.25% Convertible Senior Notes Offering (up..
BU
09/22OMNICELL, INC : Entry into a Material Definitive Agreement, Other Events, Financ..
AQ
09/22OMNICELL : Announces Proposed Private Placement of $500 Million of Convertible S..
BU
09/01OMNICELL : to Present at Upcoming Investor Conferences
BU
08/17OMNICELL : Peninsula Regional Medical Center Extends Partnership With Omnicell t..
BU
08/12OMNICELL : to Acquire Pharmaceutical Strategy Group's Leading 340B Software-Enab..
BU
07/31OMNICELL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
07/29OMNICELL : 2Q Earnings Snapshot
AQ
More news
News in other languages on OMNICELL, INC.
2016OMNICELL, INC. : Veröffentlichung des Quartalsergebnisses
2016OMNICELL, INC. : publication des résultats trimestriels
2013OMNICELL, INC. : publication des résultats trimestriels
2013OMNICELL, INC. : publication des résultats trimestriels
More news
Chart OMNICELL, INC.
Duration : Period :
Omnicell, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OMNICELL, INC.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 80,63 $
Last Close Price 84,47 $
Spread / Highest target 18,4%
Spread / Average Target -4,55%
Spread / Lowest Target -30,2%
EPS Revisions
Managers
NameTitle
Randall A. Lipps Chairman, President & Chief Executive Officer
Bill Wingfield Vice President-North America Service & Operations
Peter J. Kuipers Chief Financial Officer & Executive Vice President
Giri Chodavarapu Chief Information Officer
Sara J. White Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
OMNICELL, INC.3.37%3 612
VEEVA SYSTEMS INC.111.04%44 773
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED126.11%35 297
SECTRA AB (PUBL)54.99%2 660
PRO MEDICUS LIMITED50.47%2 492
B-SOFT CO.,LTD.12.79%2 389